Description
The field of neuromuscular diseases has been revolutionized in the last 10 years by the application of genetic technologies that are rapidly evolving. This revolution has changed how we diagnose, clinically classify and treat neuromuscular disorders. Therefore, it is important that professionals in neuromuscular diseases understand and are able to utilize these methods in their prospective future career.
This module aims to give you a sound understanding of the genetic technologies used in clinical research for neuromuscular diseases. It covers research technologies from classic Sanger sequencing to next generation sequencing and genome wide association studies that are used to identify novel disease-causing mutations and disease modifier genes. These methods are crucial for understanding the potential and significance of genetic research into neuromuscular diseases, over 60% of which are hereditary diseases. The course also covers new genetic technologies developed for the treatment of neuromuscular disorders including gene therapy and RNA-based therapies. Ethical considerations in the context of genetic research and genetic counselling will be introduced. Finally, the module includes a grant writing workshop with practical guidance on how to formulate your research ideas and develop them in the form of a grant application.Ìý
Module deliveries for 2024/25 academic year
Last updated
This module description was last updated on 19th August 2024.
Ìý